Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of AMPI, IOMP and AFOMP      
 Users online: 581  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
Year : 2010  |  Volume : 35  |  Issue : 4  |  Page : 189-196

Implementation and validation of a commercial portal dosimetry software for intensity-modulated radiation therapy pre-treatment verification

1 Department of Medical Physics, University Hospital, Udine - 33100; Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Hosur Road, Bangalore - 560 029, India
2 Department of Medical Physics, University Hospital, Udine - 33100, India
3 Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Hosur Road, Bangalore - 560 029, India

Correspondence Address:
Eugenia Moretti
Medical Physicist, Department of Medical Physics, University Hospital, Udine - 33100, Italy

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-6203.71758

Rights and Permissions

Electronic portal imaging devices (EPIDs) are extensively used for obtaining dosimetric information of pre-treatment field verification and in-vivo dosimetry for intensity-modulated radiotherapy (IMRT). In the present study, we have implemented the newly developed portal dosimetry software using independent dose prediction algorithm EPIDose TM and evaluated this new tool for the pre-treatment IMRT plan quality assurance of Whole Pelvis with Simultaneous Integrated Boost (WP-SIB-IMRT ) of prostate cases by comparing with routine two-dimensional (2D) array detector system (MapCHECK TM ). We have investigated 104 split fields using g-distributions in terms of predefined g frequency parameters. The mean γ values are found to be 0.42 (SD: 0.06) and 0.44 (SD: 0.06) for the EPIDose and MapCHECK TM , respectively. The average g∆ for EPIDose and MapCHECK TM are found as 0.51 (SD: 0.06) and 0.53 (SD: 0.07), respectively. Furthermore, the percentage of points with g < 1, γ < 1.5, and γ > 2 are 97.4%, 99.3%, and 0.56%, respectively for EPIDose and 96.4%, 99.0% and 0.62% for MapCHECK TM . Based on our results obtained with EPIDose and strong agreement with MapCHECK TM , we may conclude that the EPIDose portal dosimetry system has been successfully implemented and validated with our routine 2D array detector

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded395    
    Comments [Add]    
    Cited by others 1    

Recommend this journal